Literature DB >> 7899143

Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion.

A Noël1, H Emonard, M Polette, P Birembaut, J M Foidart.   

Abstract

We have studied the role of the extracellular matrix and host cells in tumor progression and tumor invasion. Our results emphasize the importance of tumoral cell-host cell interactions during this process. Addition of human fibroblasts and/or basement membrane components to human mammary adenocarcinoma cells, when injected into athymic nude mice, results in an increase of take and growth rate of the tumors. Peritumoral extracellular matrix is remodeled through multiple mechanisms: overproduction of matrix components by fibroblasts, enhanced fibroblasts proliferation, modulation of interstitial collagenase production by fibroblasts and retraction of the matrix by tumoral cells. The degradation of basement membranes during the metastatic process is often associated with the secretion of proteolytic enzymes. The 72 kDa type IV collagenase, a metalloproteinase, can be produced by some tumoral cells. However, it appears also to be secreted by peritumoral stromal fibroblasts under the influence of tumoral cells. We have demonstrated the existence of a binding site for this enzyme on the membrane of mammary tumoral cells. These results suggest a cooperation between tumor cells and fibroblasts during basement membrane destruction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899143     DOI: 10.1016/S0344-0338(11)80999-4

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  10 in total

1.  Muscularis mucosae in desmoplastic stroma formation of early invasive rectal adenocarcinoma.

Authors:  Shinichi Ban; Michio Shimizu
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

2.  Medulloblastoma displays distinct regional matrix metalloprotease expression.

Authors:  G H Vince; C Herbold; R Klein; J Kühl; T Pietsch; S Franz; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.

Authors:  R E Seftor; E A Seftor; J E De Larco; D E Kleiner; J Leferson; W G Stetler-Stevenson; T F McNamara; L M Golub; M J Hendrix
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

4.  Effect of MRC-5 fibroblast conditioned medium on breast cancer cell motility and invasion in vitro.

Authors:  N Heylen; R Baurain; C Remacle; A Trouet
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

Review 5.  The role of stroma in breast carcinoma growth in vivo.

Authors:  A Noël; J M Foidart
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

6.  Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.

Authors:  Ilyar Sheyhidin; Gulnaz Nabi; Ayshamgul Hasim; Rui-Ping Zhang; Julaiti Ainiwaer; Hong Ma; Hua Wang
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

7.  Establishment and characterization of a new transplantable pancreatic cancer xenograft (PZX-5) in immunosuppressed mice.

Authors:  A Zalatnai; J Bocsi; F Timár; I Babó
Journal:  Int J Pancreatol       Date:  1998-02

8.  Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.

Authors:  Salomé González-Reyes; Laura Marín; Lucía González; Luis O González; José M del Casar; Maria L Lamelas; José M González-Quintana; Francisco J Vizoso
Journal:  BMC Cancer       Date:  2010-12-03       Impact factor: 4.430

9.  The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC.

Authors:  Lei Li; Guo-Dong Zhao; Zhe Shi; Li-Li Qi; Li-Yuan Zhou; Ze-Xian Fu
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

10.  CUL4A promotes cell invasion in gastric cancer by activating the NF-κB signaling pathway.

Authors:  Yu Gong; Xiao-Jun Xiang; Miao Feng; Jun Chen; Zi-Ling Fang; Jian-Ping Xiong
Journal:  Biologics       Date:  2017-04-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.